SCHEMBL7840091

SCHEMBL7840091

CCOC(=O)C(c1ccc2c(c1)OCO2)C(C=O)c1ccc(C#N)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CRHBP P24387 1/20 0.47
CRHR2 Q13324 1/20 0.47
MAPT P10636 5/20 0.43
SMN1; SMN2 Q16637 4/20 0.43
KDM4E B2RXH2 6/20 0.42
NPC1 O15118 4/20 0.42
RAB9A P51151 4/20 0.42
HPGD P15428 4/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
HTT P42858 1/20 0.42
LMNA P02545 1/20 0.42
MAPK1 P28482 1/20 0.42
ALDH1A1 P00352 5/20 0.41
GAA P10253 2/20 0.41
OGA O60502 2/20 0.39
TDP1 Q9NUW8 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7841290 0.88 RAB9A (0.46) CRHBPCRHR2MAPTKDM4ENPC1
SCHEMBL7831716 0.86 RAB9A (0.44) CRHBPCRHR2MAPTKDM4ENPC1
SCHEMBL7839027 0.86 KDM4E (0.49) CRHBPCRHR2MAPTSMN1; SMN2KDM4E
SCHEMBL7842489 0.86 RAB9A (0.44) CRHBPCRHR2MAPTKDM4ENPC1
SCHEMBL8152135 0.85 KMT2A (0.57) MAPTSMN1; SMN2KDM4ENPC1RAB9A
SCHEMBL7838582 0.85 MAPT (0.55) MAPTSMN1; SMN2KDM4ENPC1RAB9A
SCHEMBL7842082 0.84 NPC1 (0.44) CRHBPCRHR2MAPTKDM4ENPC1
SCHEMBL27378630 0.84 CYP3A4 (0.43) CRHBPCRHR2MAPTKDM4ENPC1
SCHEMBL7843720 0.84 KDM4E (0.44) CRHBPCRHR2MAPTSMN1; SMN2KDM4E
SCHEMBL7839857 0.83 KDM4E (0.43) CRHBPCRHR2MAPTKDM4ENPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1072660-C 2,1,3-benzothia (oxa) diazole derivatives having an endothelin receptor antagonistic effect MERCK PATENT GMBH (DE) 2001-10-10 CN disclosed
EP-0882030-B1 2,1,3-BENZOTHIA(OXA)DIAZOLE DERIVATIVES HAVING AN ENDOTHELIN RECEPTOR ANTAGONISTIC EFFECT MERCK PATENT GMBH (DE) 2001-09-12 EP disclosed
US-6017939-A 2,1,3-benzothia(OXA)diazole derivatives having an endothelin receptor antagonistic effect MERCK PATENT GESELLSCHAFT (DE) 2000-01-25 US disclosed
CN-1216540-A 2,1,3-benzothia (oxa) diazole derivatives having an endothelin receptor antagonistic effect MERCK PATENT GES MIT BESCHRIKT (DE) 1999-05-12 CN disclosed